Longitude Venture Partners II L.P. 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:44 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Longitude Venture Partners II L.P. | 1,616,070 3.100% | 1,616,070 (New Position) | Filing |